Transformation of Antibody Status in HIV/AIDS Patients Treated with Medicinal synthetic Aluminum-magnesium silicate {Al4 (SiO4)3 + 3Mg2SiO4 → 2Al2Mg3 (SiO4)3}

Since viruses and abnormal cells are electrically charged, we postulated opposite charges electrostatic-mopping as treatment-mechanism for viral diseases and tumors. Molecules of Aluminum-magnesium silicate (AMS), WHO- approved medicine/adjuvant, consist of Nano- particles with positive and negative ends. Their ultra-small size (0.96 nm) enables them get to all organs to mop viruses and abnormal cells. As an adjuvant and a silicate, AMS improves antimicrobials` efficacies and enhances patients` immunity. Mopping HIV and HIV-infected cells, clearing secondary infections and enhancing immunity cure viral diseases and tumors. AMS-deposits may not exist in some countries and the medicine is un-absorbable. So, Aluminum silicate and Magnesium silicate (approved medicines) were used to formulate AMS-brand, named Medicinal synthetic AMS {MSAMS: Al4 (SiO4)3 + 3Mg2SiO4 → 2Al2Mg3 (SiO4)3}. Dextrose monohydrate was incor- porated to transport it into blood-circulation. That MSAMS-treated patient remained HIV- negative, 10 months post treatment has already been reported. Another patient monitored for 34 months also remained negative.

Article file ID not found.

The authors declare no conflict of interest.

Not applicable

The datasets used in this study are openly available at [repository link] and the source code is available on GitHub at [GitHub link].

This work did not receive any external funding.